BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19300040)

  • 1. Population pharmacokinetics of ketorolac in neonates and young infants.
    Zuppa AF; Mondick JT; Davis L; Cohen D
    Am J Ther; 2009; 16(2):143-6. PubMed ID: 19300040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative ketorolac tromethamine use in infants aged 6-18 months: the effect on morphine usage, safety assessment, and stereo-specific pharmacokinetics.
    Lynn AM; Bradford H; Kantor ED; Seng KY; Salinger DH; Chen J; Ellenbogen RG; Vicini P; Anderson GD
    Anesth Analg; 2007 May; 104(5):1040-51, tables of contents. PubMed ID: 17456651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of intravenous use of ketorolac in infants following cardiothoracic surgery.
    Dawkins TN; Barclay CA; Gardiner RL; Krawczeski CD
    Cardiol Young; 2009 Feb; 19(1):105-8. PubMed ID: 19134246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children.
    Kauffman RE; Lieh-Lai MW; Uy HG; Aravind MK
    Clin Pharmacol Ther; 1999 Apr; 65(4):382-8. PubMed ID: 10223774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine disposition in children; a population analysis.
    Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
    Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of single-dose intravenous ketorolac in infants aged 2-11 months.
    Cohen MN; Christians U; Henthorn T; Vu Tran Z; Moll V; Zuk J; Galinkin J
    Anesth Analg; 2011 Mar; 112(3):655-60. PubMed ID: 21233498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of intravenous ketorolac in children aged 2 months to 16 years: A population analysis.
    McLay JS; Engelhardt T; Mohammed BS; Cameron G; Cohen MN; Galinkin JL; Christians U; Avram MJ; Henthorn TK; Dsida RM; Hawwa AF; Anderson BJ
    Paediatr Anaesth; 2018 Feb; 28(2):80-86. PubMed ID: 29266539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of ketorolac in neonates and infants after cardiac surgery.
    Moffett BS; Wann TI; Carberry KE; Mott AR
    Paediatr Anaesth; 2006 Apr; 16(4):424-8. PubMed ID: 16618297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How readily does ketorolac penetrate cerebrospinal fluid in children?
    Kumpulainen E; Kokki H; Laisalmi M; Heikkinen M; Savolainen J; Rautio J; Lehtonen M
    J Clin Pharmacol; 2008 Apr; 48(4):495-501. PubMed ID: 18272673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ketorolac (toradol) in hand surgery.
    Pichard CP; Laporte DM
    J Hand Surg Am; 2009 Oct; 34(8):1549-50. PubMed ID: 19524375
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacokinetics of ketorolac after single postoperative intranasal administration in adolescent patients.
    Drover DR; Hammer GB; Anderson BJ
    Anesth Analg; 2012 Jun; 114(6):1270-6. PubMed ID: 22467894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketorolac for paediatric postoperative pain. A review.
    Di Massa A; Scardigli M; Bruni L; Valentino L
    Minerva Anestesiol; 2000 Oct; 66(10):749-56. PubMed ID: 11194983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation.
    Barañano DE; Kim SJ; Edelhauser HF; Durairaj C; Kompella UB; Handa JT
    Br J Ophthalmol; 2009 Oct; 93(10):1387-90. PubMed ID: 19628498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturational pharmacokinetics of single intravenous bolus of propofol.
    Allegaert K; de Hoon J; Verbesselt R; Naulaers G; Murat I
    Paediatr Anaesth; 2007 Nov; 17(11):1028-34. PubMed ID: 17897267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of ketorolac in surgical neonates and infants 0 to 3 months old.
    Aldrink JH; Ma M; Wang W; Caniano DA; Wispe J; Puthoff T
    J Pediatr Surg; 2011 Jun; 46(6):1081-5. PubMed ID: 21683202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of routine monitoring data for determination of the population pharmacokinetics and enteral bioavailability of phenytoin in neonates and infants with seizures.
    Al Za'abi M; Lanner A; Xiaonian X; Donovan T; Charles B
    Ther Drug Monit; 2006 Dec; 28(6):793-9. PubMed ID: 17164696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketorolac tromethamine: stereo-specific pharmacokinetics and single-dose use in postoperative infants aged 2-6 months.
    Lynn AM; Bradford H; Kantor ED; Andrew M; Vicini P; Anderson GD
    Paediatr Anaesth; 2011 Mar; 21(3):325-34. PubMed ID: 21199130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diclofenac and metabolite pharmacokinetics in children.
    van der Marel CD; Anderson BJ; Rømsing J; Jacqz-Aigrain E; Tibboel D
    Paediatr Anaesth; 2004 Jun; 14(6):443-51. PubMed ID: 15153204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intravenous ketorolac in the neonate and premature babies.
    Papacci P; De Francisci G; Iacobucci T; Giannantonio C; De Carolis MP; Zecca E; Romagnoli C
    Paediatr Anaesth; 2004 Jun; 14(6):487-92. PubMed ID: 15153212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.